Cyclerion Therapeutics (CYCN) EPS (Weighted Average and Diluted) (2021 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly EPS (Weighted Average and Diluted) of -$0.31 in Q3 2025, up 42.71% quarter-over-quarter from -$0.54 in Q2 2025.
Cyclerion Therapeutics (CYCN) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Cyclerion Therapeutics' EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$0.31 for Q3 2025.
- In Q3 2025, EPS (Weighted Average and Diluted) changed N/A year-over-year to -$0.31; the TTM figure through Sep 2025 stood at -$0.31 (changed N/A YoY), while the FY2023 annual figure was $3.14, up 410.41% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.31 for Q3 2025 at Cyclerion Therapeutics, up from -$0.54 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $4.84 in Q3 2023 to a low of -$6.16 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.49 across 4 years, with a median of -$0.3 in 2022.
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) sank 1268.89% in 2022, then surged 2115.14% in 2023.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.24 in 2021, then jumped by 33.33% to -$0.16 in 2022, then soared by 3122.7% to $4.84 in 2023, then tumbled by 106.45% to -$0.31 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.31 (Q3 2025), -$0.54 (Q2 2025), and -$0.57 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.54 |
| Mar 31, 2025 | -0.57 |
| Sep 30, 2023 | 4.84 |
| Jun 30, 2023 | -1.83 |
| Mar 31, 2023 | -0.16 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -6.16 |
| Mar 31, 2022 | -0.30 |
| Dec 31, 2021 | -0.24 |
| Sep 30, 2021 | -0.26 |
| Jun 30, 2021 | -0.45 |